LEUKEMIA CUTIS

Clinical trials for LEUKEMIA CUTIS explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA CUTIS trials appear

Sign up with your email to follow new studies for LEUKEMIA CUTIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial aims to improve survival for kids with High-Risk leukemia

Disease control Ongoing

This large, late-stage trial is testing whether adding the drugs bortezomib or sorafenib to standard chemotherapy can better control a fast-growing blood cancer called acute myeloid leukemia (AML) in children and young adults. It focuses on patients with a specific high-risk gene…

Matched conditions: LEUKEMIA CUTIS

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

LEUKEMIA CUTIS

Get alerted when new LEUKEMIA CUTIS trials appear

Major trial aims to improve survival for kids with High-Risk leukemia